The DOI matches its Crossref record; 280 of the 280 references it cites were found in a registry or an index.
Dynamic EMT: a multi‐tool for tumor progression
Open accessAbstract
The process of epithelial-mesenchymal transition (EMT) is fundamental for embryonic morphogenesis. Cells undergoing it lose epithelial characteristics and integrity, acquire mesenchymal features, and become motile. In cancer, this program is hijacked to confer essential changes in morphology and motility that fuel invasion. In addition, EMT is increasingly understood to orchestrate a large variety of complementary cancer features, such as tumor cell stemness, tumorigenicity, resistance to therapy and adaptation to changes in the microenvironment. In this review, we summarize recent findings related to these various classical and non-classical functions, and introduce EMT as a true tumorigenic multi-tool, involved in many aspects of cancer. We suggest that therapeutic targeting of the EMT process will-if acknowledging these complexities-be a possibility to concurrently interfere with tumor progression on many levels.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–280 of 280
Lee, C.-C., Lin, J.-C., Hwang, W., Kuo, Y., Chen, H.-K., Tai, S., Lin, C., & Yang, M. (2018) · Nature Communications · doi:10.1038/s41467-018-06268-0 · Cited by 158
Makrodouli, E., Oikonomou, E., Koc, M., Anděra, L., Sasazuki, T., Shirasawa, S., & Pintzas, A. (2011) · Molecular Cancer · doi:10.1186/1476-4598-10-118 · Cited by 156
ZEB1‐mediated melanoma cell plasticity enhances resistance to MAPK inhibitors
Richard, G., Dalle, S., Monet, M., Plaschka, M., Boespflug, A. M., Pommier, R. M., de la Fouchardière, A., Perier‐Muzet, M., Depaepe, L., Barnault, R., et al. (2016) · EMBO Molecular Medicine · doi:10.15252/emmm.201505971 · Cited by 152
A Wnt-Induced Phenotypic Switch in Cancer-Associated Fibroblasts Inhibits EMT in Colorectal Cancer
Mosa, M. H., Michels, B. E., Menche, C., Nicolas, A. M., Darvishi, T., Greten, F. R., & Farin, H. F. (2020) · Cancer Research · doi:10.1158/0008-5472.can-20-0263 · Cited by 150
Diepenbruck, M., Waldmeier, L., Ivánek, R., Berninger, P., Arnold, P., van Nimwegen, E., & Christofori, G. (2014) · Journal of Cell Science · doi:10.1242/jcs.139865 · Cited by 149
Uttamsingh, S., Bao, X., Nguyen, K. T., Bhanot, M., Gong, J., Chan, J., Liu, F., Chu, T.-Y., & Wang, L. (2007) · Oncogene · doi:10.1038/sj.onc.1210915 · Cited by 146
Prrx1 isoform switching regulates pancreatic cancer invasion and metastatic colonization
Takano, S., Reichert, M., Bakir, B. S., Das, K. K., Nishida, T., Miyazaki, M., Heeg, S., Collins, M. A., Marchand, B., Hicks, P. D., et al. (2016) · Genes & Development · doi:10.1101/gad.263327.115 · Cited by 142
Mao, Z., Zhang, J., Shi, Y., Li, W., Shi, H., Ji, R., Mao, F., Qian, H., Xu, W., & Zhang, X. (2020) · Oncogenesis · doi:10.1038/s41389-020-00249-z · Cited by 142
Che, D., Zhang, S., Jing, Z., Shang, L., Jin, S., Liu, F., Shen, J., Li, Y., Hu, J., Meng, Q., et al. (2017) · Molecular Immunology · doi:10.1016/j.molimm.2017.06.018 · Cited by 138
Musashi2 promotes EGF-induced EMT in pancreatic cancer via ZEB1-ERK/MAPK signaling
Sheng, W., Shi, X., Lin, Y., Tang, J., Jia, C., Cao, R., Sun, J. H., Wang, G., Zhou, L., & Dong, M. (2020) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-020-1521-4 · Cited by 137
Kim, J., Kong, J., Chang, H., Kim, H., & Kim, A. (2016) · Oncotarget · doi:10.18632/oncotarget.13116 · Cited by 136
ZEB1 confers chemotherapeutic resistance to breast cancer by activating ATM
Zhang, X., Zhang, Z., Zhang, Q., Zhang, Q., Sun, P., Xiang, R., Ren, G., & Yang, S. (2018) · Cell Death and Disease · doi:10.1038/s41419-017-0087-3 · Cited by 136
Tumor-Associated Neutrophils and Macrophages—Heterogenous but Not Chaotic
Wu, L., & Zhang, X. H.-F. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.553967 · Cited by 135
Xu, Y., Lee, D.-K., Feng, Z., Xu, Y., Bu, W., Li, Y., Liao, L., & Xu, J. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1618091114 · Cited by 130
Ho, M.-Y., Tang, S., Chuang, M., Cha, T., Li, J.-Y., Sun, G.-H., & Sun, K. (2012) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-12-0160 · Cited by 125
Comaills, V., Kabeche, L., Morris, R., Buisson, R., Yu, M., Madden, M. W., LiCausi, J. A., Boukhali, M., Tajima, K., Pan, S., et al. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.11.022 · Cited by 124
ZEB 1‐regulated inflammatory phenotype in breast cancer cells
Katsura, A., Tamura, Y., Hokari, S., Harada, M., Morikawa, M., Sakurai, T., Takahashi, K., Mizutani, A., Nishida, J., Yokoyama, Y., et al. (2017) · Molecular Oncology · doi:10.1002/1878-0261.12098 · Cited by 124
Huang, C.-H., Yang, W., Chang, S., Tai, S., Tzeng, C., Kao, J., Wu, K.-J., & Yang, M. (2009) · Neoplasia · doi:10.1593/neo.91326 · Cited by 123
Gubelmann, C., Schwalie, P. C., Raghav, S. K., Roeder, E., Challa, T. D., Kiehlmann, E., Waszak, S. M., Corsinotti, A., Udin, G., Holcombe, W., et al. (2014) · eLife · doi:10.7554/elife.03346 · Cited by 122
Ren, J., Chen, Y., Song, H., Chen, L., & Wang, R. (2012) · Journal of Cellular Biochemistry · doi:10.1002/jcb.24481 · Cited by 119
Kmieciak, M., Knutson, K. L., Dumur, C. I., & Manjili, M. H. (2007) · European Journal of Immunology · doi:10.1002/eji.200636639 · Cited by 118
MicroRNA-200a suppresses the Wnt/β-catenin signaling pathway by interacting with β-catenin
Kang, C. (2011) · International Journal of Oncology · doi:10.3892/ijo.2011.1322 · Cited by 116
Jung, A. R., Jung, C., Noh, J. K., Lee, Y. C., & Eun, Y. (2020) · Scientific Reports · doi:10.1038/s41598-020-60707-x · Cited by 115
Pistore, C., Giannoni, E., Colangelo, T., Rizzo, F. M., Magnani, E., Muccillo, L., Giurato, G., Mancini, M., Rizzo, S., Riccardi, M., et al. (2017) · Oncogene · doi:10.1038/onc.2017.159 · Cited by 114
Radiation induces epithelial-mesenchymal transition in colorectal cancer cells
Kawamoto, A. (2011) · Oncology Reports · doi:10.3892/or.2011.1485 · Cited by 113
Devarajan, E., Song, Y., Krishnappa, S., & Alt, E. (2011) · International Journal of Cancer · doi:10.1002/ijc.26493 · Cited by 112
He, X., Yan, B., Liu, S., Jia, J., Lai, W., Xing, X., Tang, C., Luo, D., Tan, T., Jiang, Y., et al. (2016) · Cancer Research · doi:10.1158/0008-5472.can-16-0268 · Cited by 112
An integrated analysis identifies STAT4 as a key regulator of ovarian cancer metastasis
Zhao, L., Ji, G., Le, X., Luo, Z., Wang, C., Feng, M., Xu, L., Zhang, Y., Lau, W. B., Lau, B., et al. (2017) · Oncogene · doi:10.1038/onc.2016.487 · Cited by 110
Inadequate DNA Damage Repair Promotes Mammary Transdifferentiation, Leading to BRCA1 Breast Cancer
Wang, H., Xiang, D., Liu, B., He, A., Randle, H. J., Zhang, K. X., Dongre, A., Sachs, N., Clark, A. P., Tao, L., et al. (2019) · Cell · doi:10.1016/j.cell.2019.06.002 · Cited by 110
Snail Up-regulates Proinflammatory Mediators and Inhibits Differentiation in Oral Keratinocytes
Lyons, J. G., Patel, V., Roue, N. C., Fok, S., Soon, L., Halliday, G. M., & Gutkind, J. S. (2008) · Cancer Research · doi:10.1158/1078-0432.ccr-07-6735 · Cited by 107
Miao, J., Liú, L., & Huang, J. (2014) · International Journal of Oncology · doi:10.3892/ijo.2014.2422 · Cited by 107
CXCR2+ MDSCs promote breast cancer progression by inducing EMT and activated T cell exhaustion
Zhu, H., Gu, Y., Xue, Y., Yuan, M., Cao, X., & Liu, Q. (2017) · Oncotarget · doi:10.18632/oncotarget.23020 · Cited by 106
The Hippo Signaling Pathway in Pancreatic Cancer
Ansari, D., OHLSSON, H., Althini, C., Bauden, M. P., Zhou, Q., Hu, D., & Andersson, R. E. (2019) · Anticancer Research · doi:10.21873/anticanres.13474 · Cited by 104
YAP and TAZ are essential for basal and squamous cell carcinoma initiation
Debaugnies, M., Sánchez‐Danés, A., Rorive, S., Raphaël, M., Liagre, M., Parent, M.-A., Brisebarre, A., Salmon, I. J., & Blanpain, C. (2018) · EMBO Reports · doi:10.15252/embr.201845809 · Cited by 103
Tumor-Contacted Neutrophils Promote Metastasis by a CD90-TIMP-1 Juxtacrine–Paracrine Loop
Wang, Y., Chen, J., Yang, L., Li, J., Wu, W., Huang, M., Lin, L., & Su, S. (2018) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-18-2544 · Cited by 102
Liu, Z., Tu, K., Wang, Y., Yao, B., Li, Q., Wang, L., Dou, C., Liu, Q., & Zheng, X. M. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000485821 · Cited by 94
Ma, X., Wang, M., Yin, T., Zhao, Y., & Wei, X. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.00855 · Cited by 92
Maehara, O., Suda, G., Natsuizaka, M., Ohnishi, S., Komatsu, Y., Sato, F., Nakai, M., Sho, T., Morikawa, K., Ogawa, K., et al. (2017) · Carcinogenesis · doi:10.1093/carcin/bgx095 · Cited by 90
Novel clinical therapeutics targeting the epithelial to mesenchymal transition
Kothari, A. N., Mi, Z., Zapf, M. A. C., & Kuo, P. C. (2014) · Clinical and Translational Medicine · doi:10.1186/s40169-014-0035-0 · Cited by 84
The Engagement Between MDSCs and Metastases: Partners in Crime
Trovato, R., Canè, S., Petrova, V., Sartoris, S., Ugel, S., & Sanctis, F. D. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.00165 · Cited by 79
Antiestrogens Induce Transforming Growth Factor β–Mediated Immunosuppression in Breast Cancer
Joffroy, C. M., Buck, M. B., Stope, M. B., Popp, S. L., Pfizenmaier, K., & Knabbe, C. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-3292 · Cited by 76
Different thresholds of ZEB1 are required for Ras-mediated tumour initiation and metastasis
Liu, Y., Lu, X., Huang, L., Wang, W., Jiang, G., Dean, K. C., Clem, B. F., Telang, S., Jenson, A. B., Cuatrecasas, M., et al. (2014) · Nature Communications · doi:10.1038/ncomms6660 · Cited by 75
Goebel, L., Grage‐Griebenow, E., Gorys, A., Helm, O., Genrich, G., Lenk, L., Wesch, D., Ungefroren, H., Freitag‐Wolf, S., Sipos, B., et al. (2015) · OncoImmunology · doi:10.1080/2162402x.2014.1000083 · Cited by 75
Zhang, D., Liu, Y., Liu, X., Gao, J., Liu, T., Yan, Q., & Yang, X. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.29252 · Cited by 75
Liu, J., Ruan, B., You, N., Huang, Q., Liu, W., Dang, Z., Xu, W., Zhou, T., Ji, R., Cao, Y., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0079409 · Cited by 74
Geng, Y., Fan, J., Chen, L., Zhang, C., Qu, C., Qian, L., Chen, K., Meng, Z., Chen, Z., & Wang, P. (2020) · Cancer Research · doi:10.1158/0008-5472.can-20-0256 · Cited by 73
The ZEB1/miR-200c feedback loop regulates invasion via actin interacting proteins MYLK and TKS5
Sundararajan, V., Gengenbacher, N., Stemmler, M. P., Kleemann, J., Brabletz, T., & Brabletz, S. (2015) · Oncotarget · doi:10.18632/oncotarget.4807 · Cited by 72
Self-citationLin, J., Tsai, J.-T., Chao, T.-Y., Ma, H.-I., & Liu, W. (2018) · Cancers · doi:10.3390/cancers10120512 · Cited by 70
Liu, L., Chen, X., Wang, Y., Qu, Z., Lü, Q., Zhao, J., Yan, X., Zhang, H., & Zhou, Y. (2014) · Cancer Gene Therapy · doi:10.1038/cgt.2014.39 · Cited by 68
Tian, Y., Chen, Y., Chang, C.-T., Hung, C., Wu, M.-S., Phillips, A. O., & Yang, C. (2007) · Experimental Cell Research · doi:10.1016/j.yexcr.2007.03.022 · Cited by 68
The Kraken Wakes: induced EMT as a driver of tumour aggression and poor outcome
Redfern, A. D., Spalding, L. J., & Thompson, E. W. (2018) · Clinical & Experimental Metastasis · doi:10.1007/s10585-018-9906-x · Cited by 68
Contribution of Epithelial Plasticity to Therapy Resistance
Santamaría, P. G., Moreno‐Bueno, G., & Cano, A. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8050676 · Cited by 68
Matise, L. A., Palmer, T. D., Ashby, W. J., Nashabi, A., Chytil, A., Aakre, M. E., Pickup, M. W., Gorska, A. E., Zijlstra, A., & Moses, H. L. (2012) · Breast Cancer Research · doi:10.1186/bcr3217 · Cited by 67
Zeb2 drives invasive and microbiota-dependent colon carcinoma
Slowicka, K., Πέττα, Ι., Blancke, G., Hoste, E., Dumas, E., Sze, M., Vikkula, H., Radaelli, E., Haigh, J. J., Jonckheere, S., et al. (2020) · Nature Cancer · doi:10.1038/s43018-020-0070-2 · Cited by 66
FHIT loss confers cisplatin resistance in lung cancer via the AKT/NF-κB/Slug-mediated PUMA reduction
Wu, D., Lee, M.-C., Hsu, N.-Y., Wu, T.-C., Wu, J.-Y., Wang, Y.-C., Cheng, Y.-W., Chen, C.-Y., & Lee, H. (2014) · Oncogene · doi:10.1038/onc.2014.184 · Cited by 63
Sun, D., Luo, T., Dong, P., Zhang, N., Chen, J., Zhang, S., Dong, L., Janssen, H. L. A., & Zhang, S. (2019) · Journal of Cellular Biochemistry · doi:10.1002/jcb.29514 · Cited by 63
Loss of Slug Compromises DNA Damage Repair and Accelerates Stem Cell Aging in Mammary Epithelium
Gross, K. M., Zhou, W., Breindel, J. L., Ouyang, J., Jin, D. X., Sokol, E. S., Gupta, P. B., Huber, K., Zou, L., & Kuperwasser, C. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.06.043 · Cited by 58
Wang, Y., Liao, R., Chen, X., Ying, X., Chen, G., Li, M., & Dong, C. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-2725-4 · Cited by 54
Sun, N.-Y., & Yang, M. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.00792 · Cited by 53
An Autocrine IL-6/IGF-1R Loop Mediates EMT and Promotes Tumor Growth in Non-small Cell Lung Cancer
Zheng, X., Lu, G., Yao, Y., & Gu, W. (2019) · International Journal of Biological Sciences · doi:10.7150/ijbs.31999 · Cited by 49
Ieda, T., Tazawa, H., Okabayashi, H., Yano, S., Shigeyasu, K., Kuroda, S., Ohara, T., Noma, K., Kishimoto, H., Nishizaki, M., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-52816-z · Cited by 48
E-cadherin expression: a counterbalance for cancer cell invasion.
Mareel, M., Vleminckx, K., Vermeulen, S. J. T., Bracke, M., & Roy, F. M. V. (1992) · PubMed · Cited by 47
Sakata, J., Utsumi, F., Suzuki, S., Niimi, K., Yamamoto, E., Shibata, K., Senga, T., Kikkawa, F., & Kajiyama, H. (2017) · Oncotarget · doi:10.18632/oncotarget.20107 · Cited by 47
SFRP1 reduction results in an increased sensitivity to TGF-β signaling
Gauger, K. J., Chenausky, K. L., Murray, M. E., & Schneider, S. S. (2011) · BMC Cancer · doi:10.1186/1471-2407-11-59 · Cited by 45
Zhu, G., Li, X., Guo, B., Ke, Q., Dong, M., & Li, F. (2015) · Oncogene · doi:10.1038/onc.2015.259 · Cited by 41
Hara, J., Miyata, H., Yamasaki, M., Sugimura, K., Takahashi, T., Kurokawa, Y., Nakajima, K., Takiguchi, S., Mori, M., & Doki, Y. (2013) · Oncology Reports · doi:10.3892/or.2013.2876 · Cited by 41
Zhang, T., Liu, L., Wei, L., Zeng, Y., Xu, H., Lan, Q., Su, P., & Chu, Z. (2019) · Oncology Reports · doi:10.3892/or.2019.7049 · Cited by 40
Fsp1-Mediated Lineage Tracing Fails to Detect the Majority of Disseminating Cells Undergoing EMT
Bornes, L., van Scheppingen, R. H., Beerling, E., Schelfhorst, T., Ellenbroek, S. I. J., Seinstra, D., & van Rheenen, J. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.10.107 · Cited by 39
Twist1 induces chromosomal instability (CIN) in colorectal cancer cells
Khot, M., Sreekumar, D., Jahagirdar, S., Kulkarni, A. M., Hari, K., Faseela, E. E., Sabarinathan, R., Jolly, M. K., & Sengupta, K. (2020) · Human Molecular Genetics · doi:10.1093/hmg/ddaa076 · Cited by 39
Ruh, M., Stemmler, M. P., Frisch, I., Fuchs, K., van Roey, R., Kleemann, J., Roas, M., Schuhwerk, H., Eccles, R. L., Agaimy, A., et al. (2021) · The Journal of Pathology · doi:10.1002/path.5659 · Cited by 37
Self-citationProdhomme, M. K., Pommier, R. M., Franchet, C., Fauvet, F., Bergoglio, V., Brousset, P., Morel, A., Brunac, A., Devouassoux‐Shisheboran, M., Pétrilli, V., et al. (2020) · Cancer Research · doi:10.1158/0008-5472.can-20-2626 · Cited by 35
Fumarate drives EMT in renal cancer
Sciacovelli, M., & Frezza, C. (2016) · Cell Death and Differentiation · doi:10.1038/cdd.2016.137 · Cited by 30
Gudey, S. K., Sundar, R., Heldin, C., Bergh, A. R. J., & Landström, M. (2017) · Oncotarget · doi:10.18632/oncotarget.20097 · Cited by 28
Jiang, Y., Tang, Y., Wang, S., Wu, J., Zhang, M., Pang, X., Wu, J., Chen, Y., Tang, Y., & Liang, X. (2019) · Cell Proliferation · doi:10.1111/cpr.12705 · Cited by 23
Targeting Oncoimmune Drivers of Cancer Metastasis
Kudo‐Saito, C., Ozaki, Y., Imazeki, H., Hayashi, H., Masuda, J., Ozawa, H., & Ogiwara, Y. (2021) · Cancers · doi:10.3390/cancers13030554 · Cited by 23
Song, N., Jing, W., Li, C., Bai, M., Cheng, Y., Li, H., Hou, K., Li, Y., Wang, K., Li, Z., et al. (2017) · Cell Cycle · doi:10.1080/15384101.2017.1404206 · Cited by 21
What makes leader cells arise: Intrinsic properties and support from neighboring cells
Chen, B., Wu, J., Ya-jie Tang, A., Tang, Y., & Liang, X. (2020) · Journal of Cellular Physiology · doi:10.1002/jcp.29828 · Cited by 20
Glucose Metabolism Takes Center Stage in Epithelial-Mesenchymal Plasticity
Youssef, K. K., & Nieto, M. A. (2020) · Developmental Cell · doi:10.1016/j.devcel.2020.03.021 · Cited by 15
Fifis, T., Nguyen, L. T., Malcontenti‐Wilson, C., Chan, L. S., Costa, P., Daruwalla, J., Nikfarjam, M., Muralidharan, V., Waltham, M. C., Thompson, E. W., et al. (2013) · Cancer Medicine · doi:10.1002/cam4.109 · Cited by 14
Nörz, D. S., Grottke, A., Bach, J., Herzberger, C., Hofmann, B. T., Nashan, B., Jücker, M., & Ewald, F. (2015) · Cellular Signalling · doi:10.1016/j.cellsig.2015.07.016 · Cited by 6
Cited by
The molecular mechanisms and therapeutic strategies of EMT in tumor progression and metastasis
Huang, Y., Hong, W., & Wei, X. (2022) · Journal of Hematology & Oncology · doi:10.1186/s13045-022-01347-8 · Cited by 1,032
Tumor biomarkers for diagnosis, prognosis and targeted therapy
Zhou, Y., Tao, L., Qiu, J., Xu, J., Yang, X., Zhang, Y., Tian, X., Guan, X., Cen, X., & Zhao, Y. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01823-2 · Cited by 720
Bhat, G. R., Sethi, I., Sadida, H. Q., Rah, B., Mir, R., Algehainy, N., Albalawi, I. A., Masoodi, T., Subbaraj, G. K., Jamal, F., et al. (2024) · Cancer and Metastasis Reviews · doi:10.1007/s10555-024-10172-z · Cited by 281
Xie, Y., Wang, X., Wang, W., Pu, N., & Liu, L. (2025) · Journal of Translational Medicine · doi:10.1186/s12967-025-06422-5 · Cited by 80
“Recent advances challenge the binary epithelial/mesenchymal paradigm, revealing EMT as a dynamic continuum characterized by partial transition and cellular plasticity [176].”
Yang, Y., Yang, Y., Huang, H., Song, T., Mao, S., Liu, D., Zhang, L., & Li, W. (2023) · Cell Death & Disease · doi:10.1038/s41419-023-05755-7 · Cited by 41
Metadata
- Authors
- Brabletz, S., Schuhwerk, H., Brabletz, T., & Stemmler, M. P.
- Venue
- The EMBO Journal
- Published
- 2021-08-30
- Volume
- 40
- Issue
- 18
- Pages
- e108647-e108647
- ISSN
- 0261-4189 (ISSN-L)
- 1460-2075
- OpenAlex
- W3197525499
- Cited by
- 761
- References
- 280
- FWCI
- 44.11
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.